Monoclonal antibody pairs "zipper" to target cancer July 27, 2022 By Mar de Miguel Two targets, double success. This is the logic behind a new approach that uses monoclonal antibody pairs to fight cancer.Read More
Vitamin B6 benzohydrazide platinum(II) complexes overcome cisplatin resistance in tumors July 27, 2022
Convalife acquires global rights to PI3K β/δ inhibitor from Karus July 26, 2022 By Doris Yu Convalife Pharmaceuticals Co. Ltd. acquired global rights to develop and commercialize a phosphoinositide 3-kinase (PI3K) β/δ inhibitor from Karus Therapeutics Ltd.Read More
RSS
